| URL | https://www.dddmag.com/news/2018/04/amgen-announce |
| Source | Drug Discovery and Development Magazine |
| Date Published | 04/10/2018 |
| Author Name | Amgen |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Amgen Rhode Island |
| Parent company | Amgen Inc |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 150 |
| Year reshoring announced: | 2018 |
| City reshored to: | West Greenich |
| State(s) reshored to: | RI |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | biomanufacturing |
| What domestic positive factors made reshoring more attractive? | Automation/technology, Eco-system synergies, Government Incentives, Infrastructure, Image/brand, Impact on domestic economy, Manufacturing/engineering joint innovation (R&D), Skilled workforce availability/training, Under-utilized capacity |